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1. Introduction
In the field of cell biology, sphingolipids have been
recognized not only as membrane constructs but also as key 
signaling molecules in recent years.1 In an effort to study on the 
mechanism of sphingolipid mediated biological phenomena, 
caged sphingolipids which release sphingolipids after exposure to 
UV-irradiation are needed to enable spatiotemporal control of the 
function of sphingolipids. Recently, some caged sphingolipids, 
such as ceramide 1-phosphate,2 sphingosine 1-phosphate,2,3 
sphingosine,4,5 dehydrosphingosine,5 phychosine5 and 
glycosphingolipids6 were reported (Scheme 1). In these 
molecules, a highly polar phosphate or amine moiety was 
temporarily masked by a less polar photo-responsive protective 
group to suppress their biological activity. UV-irradiation 
induces release of the phosphate or the amine moiety followed by 
drastic polarity change to recover their bioactivity. Moreover, 
ceramide is a member of the sphingolipids and is also involved in 
critical cellular events such as apoptosis.7,1 To our knowledge, 
however, a caged ceramide has not been reported so far 
presumably due to its lack of highly polar functional group 
available for caging. Therefore, we decided to design a caged 
ceramide in which the ceramide activity is recovered not via 
polarity change but via structural change. In this paper, we report
development and photo-reactivity of a caged ceramide that 
generates a parent ceramide by acyl transfer-mediated structural 
change after exposure to UV- irradiation. 
Scheme 1. Representative caged sphingolipids previously 
reported. (PG: protective group removable by UV-irradiation) 
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Scheme 2. Stimulus responsive controlling system of peptidyl 
function (PG: protective group removable by a stimulus). 
 
 
Scheme 3. Design of caged ceramide (R = functional moiety). 
 
 
Scheme 4. Reagents and conditions. (i) TFA, CH2Cl2, 76%. (ii) 12, HBTU, N,N-diisopropylethylamine, DMF, 39% for 8a, 41% for 8b. 
Chemical yields of 8a derivatives are presented in following text. (iii) stearic acid, N-(3-dimethylaminopropyl)-N’-ethylcarbodiimide 
hydrochloride (EDC·HCl), Et3N, DMAP, CH2Cl2, 99%. (iv) piperidine, DMF. (v) AcOH, EDC·HCl, 1-hydroxybenzotriazole hydrate 
(HOBt·H2O), Et3N, DMF, 78% (2 steps). (vi) HF, pyridine, 73%. 
 
 
Previously, we reported the development of stimulus-
responsive amino acids and their application to control peptidyl 
function in living cells (Scheme 2).8 In this system, an amide 
bond in peptide 1 at a C-terminal position of the stimulus-
responsive amino acid is cleaved by stimulus-induced removal of 
PG (protective group removable by a stimulus) followed by 
lactonization of trimethyl lock moiety9 to generate isopeptide 2. 
In a manner similar to a click peptide or a switch peptide,10 
isopeptide 2 can easily isomerize via O-N acyl transfer to yield a 
linear bioactive peptide under physiological conditions. 
Ceramide 6 also possesses an N-acyl 1,2-aminoalcohol unit 
similar to peptide 3 (Scheme 3). Therefore, we designed caged 
ceramide 4 composed of N-UV-responsive amino acyl moiety 
and O-stearyl moiety at 1,2-position. Upon UV-induced removal 
of o-nitrobenzyl group and subsequent lactonization followed by 
amide bond cleavage, generated O-stearyl intermediate 5 should 
easily isomerize to afford ceramide 6 via O-N acyl transfer. 
Because intracellular distribution of ceramide is a key factor in 
its biological activity,11 we planned to introduce a handle at R 
position for facile attachment of a functional moiety such as an 
3 
intracellular localization signal peptide for controlling the 
distribution of the caged ceramide in living cells. 
2. Results and discussion 
2.1. Synthesis of caged ceramide 
Model caged ceramide 11 was synthesized as shown in 
Scheme 4. For simplification, an acetyl group was introduced at 
N-terminal position of UV-responsive amino acid. Starting from 
known sphingosine derivative 7 (R = Boc),12 the Boc group was 
removed under acidic conditions, and the generated amino group 
of 7 (R = H) was acylated with racemic Fmoc protected UV-
responsive amino acid 128e using O-(benzotriazol-1-yl)-
N,N,N’,N’-tetramethyluronium hexafluorophosphate (HBTU). 
The obtained product was diastereomerically purified, and each 
diastereomer 8a or 8b was subjected to the following reactions 
respectively. The hydroxyl group of 8 was acylated with stearic 
acid to afford 9. The Fmoc group of 9 was replaced with acetyl 
group by treatment with piperidine followed by acylation with 
acetic acid. Finally, the TBDPS group was removed using 
HF/pyridine to generate model caged ceramide 11. 
2.2. UV-irradiation experiment 
First, UV-irradiation experiment of caged ceramide 11a was 
examined. Caged ceramide 11a in iPrOH13 with 0.5% (v/v) 
triethylamine was irradiated by UV (>365 nm) for 1 h, and the 
reaction mixture was stirred overnight (Scheme 5). Although 
generation of ceramide 6 was confirmed by ESI-MS and TLC 
analysis of the crude reaction mixture, isolation of that was quite 
difficult because a complex mixture was obtained after 
evaporation. We thought that the complication after evaporation 
was caused  by a  s ide react ion  of  h ighly react ive o -
nitrosobenzaldehyde or its derivative under concentrated 
conditions. Therefore, HPLC analysis of the crude material 
without evaporation was attempted. However, detection of an 
authentic sample of ceramide 6 by UV absorption was difficult 
because of its low extinction coefficient. For sensitive HPLC 
analysis of the reaction, analogous 10a possessing TBDPS group 
that absorbs UV efficiently was used rather than original 11a, 
and ceramide analogue 13 was easily detected by UV-absorption. 
Therefore, we used caged ceramide analogue 10a for HPLC 
monitoring of the UV-irradiation experiment as shown below. 
Caged ceramide analogue 10a in iPrOH/H2O = 1/1 with 0.5% 
(v/v) triethylamine was irradiated by UV (>365 nm) for 3 min,14 
and the reaction mixture was incubated at 37 °C. Reaction 
progress was monitored by HPLC, and ceramide analogue 13 
was identified by ESI-MS and comparison of retention time with 
that of an authentic sample.15 After UV-irradiation and  
 
 
Scheme 5. Reagents and conditions. 11a to 6 (R = H): UV-
irradiation (>365 nm, 1 h) in iPrOH with 0.5% (v/v) Et3N 
followed by stirring at room temperature. 10a to 13 (R = 
TBDPS): UV-irradiation (>365 nm, 3 min) in H2O/iPrOH (1/1 
(v/v)) with 0.5% (v/v) Et3N followed by incubation at 37°C 
 
Figure 1. HPLC profiles of UV-induced uncaging of caged ceramide 
analogue 10a. Reaction conditions are shown in Scheme 4. (a) Before UV 
irradiation. (b) After UV irradiation (>365 nm, 3 min) followed by incubation 
at 37 °C for 5 h. Compounds eluted at 3 to 4 min are photo-cleaved 
derivatives of UV-responsive amino acid. HPLC conditions: TOSOH TSK-
GEL (4.6 × 250 mm) with hexane/iPrOH = 99/1 (v/v) at a flow rate of 1.0 
mL/min, detection at 220 nm. 
 
 
subsequent 5 h incubation, caged ceramide analogue 10a was 
completely converted to ceramide analogue 13 as shown in 
Figure 1. This result suggests that caged ceramide 11 should also 
be converted to ceramide 6 in high purity. 
2.3. Introduction of alkyne handle on caged ceramide 
Intracellular distribution of ceramide is one of the key factors 
in its biological activity.11 Therefore, introduction of a handle to 
enable facile attachment of a functional moiety, such as an 
intracellular localization signal peptide, is of value for 
spatiotemporal control of ceramide function. In this context, we 
planned to introduce an alkyne handle on the caged ceramide for 
click chemistry with a functional moiety (Scheme 6).16 Caged 
ceramide 14 possessing an alkyne handle was synthesized 
starting from Fmoc derivative 9. Briefly, the Fmoc group of 9 
was removed by piperidine treatment, and the generated amine 
was acylated with 3-pentynoic acid. The obtained material was 
subjected to TBAF and acetic acid in THF to remove TBDPS 
group, and alkyne derivative 14 was synthesized successfully. 
Next, we examined ligation of caged ceramide 14b with a 
functional moiety (Scheme 7). For simplification of the reaction 
system, benzyl azide was used as a model of the functional 
moiety. To caged ceramide 14b in H2O/dichloromethane (1/1 
(v/v)) were added benzyl azide, CuSO4, sodium ascorbate and 
tris(1-benzyl-1H-[1,2,3]triazol-4-ylmethyl)amine (TBTA) 16;17 
ligated product 15b was obtained in 91% isolated yield. This 
result suggests that the alkyne handle on the caged ceramide is 
potentially applicable for introduction of a functional moiety. 
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Scheme 6. Reagents and conditions. (i) piperidine, DMF. (ii) 3-
pentynoic acid, EDC·HCl, HOBt·H2O, Et3N, DMF. (iii) TBAF, 




In conclusion, a caged ceramide was developed. UV-
irradiation experiment clarified that the caged ceramide with 
TBDPS group can be completely converted to the corresponding 
ceramide derivative by 3 min of UV-irradiation followed by 5 h 
of incubation at 37 °C. Introduction of an alkyne handle moiety 
on the caged ceramide was also examined, and the caged 
ceramide was successfully coupled with an azide derivative by 
click chemistry. Introduction of a functional moiety and 
biological application of the caged ceramide in living cells are 
underway. 
4. Experimental section 
4.1. General methods 
All reactions were carried out under a positive pressure of 
argon. For column chromatography, silica gel (KANTO 
KAGAKU N-60) was employed. Exact mass spectra were 
recorded on a Waters MICROMASS® LCT PREMIERTM or a 
Bruker Esquire200T. NMR spectra were measured using a JEOL 
GSX400 or a JEOL GSX300 spectrometer. For HPLC analysis, a 
TSK gel Silica-60 analytical column (TOSOH, 4.6 × 250 mm, 
flow rate at 1.0 mL/min) was employed, and eluting products 
were detected by UV at 220 nm (flow rate: 1.0 mL/min; solvent 
system: hexane and iPrOH). Photolysis was performed using 
Moritex MUV-202U with the filtered output (>365 nm) of a 3000 
mW/cm2 Hg-Xe lamp. Optical rotations were measured using a 
JASCO P-2200 polarimeter (concentration in g/100 mL).  
4.2. Synthesis of caged ceramide 
4 .2 .1 .  (2S ,3R,4E)-2 -Amino-1 -( ter t -
butyld iphenyls i lany loxy)octadec-4 -en -3 -ol  (7 (R = 
H))  
Trifluoroacetic acid (2.0 mL) was added to a solution of N-Boc 
derivative 7 (R = Boc)12 (1.50 g, 2.35 mmol) in CH2Cl2 (2.0 mL) 
at 0 °C. The resulting mixture was stirred at room temperature for 
5 h and was quenched by the addition of saturated aqueous 
solution of NaHCO3. The mixture was extracted with CH2Cl2, 
and the organic layer was washed with brine, dried over Na2SO4, 
and concentrated in vacuo. The obtained crude material was 
purified by column chromatography (hexane/AcOEt = 2/1 (v/v)) 
and 0.960 g of amine 7 (R = H) (76 %) was obtained as a 
colorless oil; [α]18D +8.80 (c 1.02, CHCl3); 1H NMR (CDCl3, 400 
MHz) δ = 0.88 (3H, t, J = 6.8 Hz), 1.06 (9H, s), 1.25 (22H, m), 
2.01 (2H, dt, J = 6.6 and 6.8 Hz), 2.93 (1H, q, J = 5.6 Hz), 3.67 
(1H, dd, J = 5.4 and 10.0 Hz), 3.70 (1H, dd, J = 5.9 and 10.0 Hz), 
4.09 (1H, dd, J = 5.6 and 6.8 Hz), 5.40 (1H, dd, J = 6.8 and 15.4 
Hz), 5.73 (1H, dt, J = 6.6 and 15.4 Hz), 7.26-7.47 (6H, m), 7.64-
7.69 (4H, m); 13C NMR (CDCl3, 75 MHz) δ = 14.0, 19.1, 22.6, 
26.7, 29.1, 29.2, 29.3, 29.4, 29.5, 29.6, 31.8, 32.2, 56.4, 65.9, 
74.0, 127.6, 129.1, 129.6, 133.1, 133.6, 135.4; HRMS (ESI-TOF) 
calcd for C34H56NO2Si ([M + H]+): 538.4080. found: 538.4078. 
4.2 .2 .  {1-[(1S ,2R,3E)-1 -  ( ter t -
Buty ld iphenyls i lany loxymethy l) -2 -hydroxyhep tadec-
3-enylcarbamoyl] -2-[2 ,4-d imethyl -6 -(2 -
n i trobenzyloxy)pheny l] -2-methy lpropyl}carbamic 
acid  9H-f luoren -9-ylmethyl  es ter  (8a,  b )  
N,N-Diisopropylethylamine (107 μL, 0.610 mmol) and HBTU 
(201 mg, 0.530 mmol) were added to a solution of carboxylic 
acid 127e (332 mg, 0.560 mmol) in DMF (1.0 mL) at room 
temperature. After 30 min of stirring at room temperature, 
TBDPS sphingosine 7 (R = H) (300 mg, 0.56 mmol) was added 
to the solution. The resulting mixture was stirred at room 
temperature for 3 h and was quenched by the addition of 5% 
(w/v) aqueous solution of KHSO4. The mixture was extracted 
with CH2Cl2, and the organic layer was washed with brine, dried 
over MgSO4, and concentrated in vacuo. The obtained crude 
product was purified by column chromatography (hexane/AcOEt 
= 10/1 (v/v)) and 243 mg of 8a (39%) and 253 mg of 8b (41%, 
less polar diastereomer of 8a) were obtained as a colorless 
amorphousness. 8a (polar diastereomer): [α]19D +0.88 (c 1.02, 
CHCl3); 1H NMR (CDCl3, 400 MHz) δ = 0.88 (3H, t, J = 6.8 Hz), 
1.00 (9H, s), 1.18-1.31 (22H, m), 1.50 (3H, s), 1.55 (3H, s), 1.91 
(2H, dt, J = 6.6 and 7.1 Hz), 2.00 (3H, s), 2.28 (3H, s), 2.97 (1H, 
br s), 3.14 (1H, dd, J = 7.3 and 9.5 Hz), 3.42 (1H, dd, J = 3.2 and 
9.5 Hz), 3.97 (1H, m), 4.15 (2H, m), 4.20 (1H, m), 4.34 (1H, m), 
5.29 (1H, dd, J = 6.6 and 15.4 Hz), 5.32 (1H, d, J = 8.3 Hz), 5.38 
(1H, d, J = 14.6 Hz), 5.48 (1H, d, J = 8.3 Hz), 5.60 (1H, d, J = 
14.6 Hz), 5.64 (1H, dt, J = 7.1 and 15.4 Hz), 5.70 (1H, d, J = 8.3 
Hz), 6.30 (1H, s), 6.47 (1H, s), 7.29 (2H, d, J = 7.8 Hz), 7.34-
7.51 (10H, m), 7.53-7.66 (6H, m), 7.75 (2H, d, J = 7.8 Hz), 7.94 
(1H, d, J = 7.8 Hz), 8.16 (1H, d, J = 7.8 Hz); 13C NMR (CDCl3, 
75 MHz) δ = 14.1, 19.0, 20.6, 22.7, 25.6, 26.7, 28.0, 29.1, 29.3, 
29.5, 29.6, 29.7, 31.9, 32.3, 45.1, 47.1, 54.4, 59.5, 62.8, 67.0, 
68.8, 73.4, 113.2, 119.9, 125.1, 125.2, 127.0, 127.6, 127.8, 128.5, 
128.8, 129.4, 129.6, 129.9, 132.5, 132.6, 133.4, 134.2, 134.4, 
135.5, 137.2, 138.5, 141.2, 143.9, 146.9, 156.2, 157.8, 171.0; 
HRMS (ESI-TOF) calcd for C69H88N3O8Si ([M + H]+): 
1114.6341, found: 1114.6370. 8b (less polar diastereomer): 
[α]18D -1.11 (c 1.09, CHCl3); 1H NMR (CDCl3, 400 MHz) δ = 
0.88 (3H, t, J = 6.8 Hz), 0.93 (9H, s), 1.26 (22H, m), 1.58 (3H, s), 
1.67 (3H, s), 1.96 (2H, q, J = 6.8 Hz), 2.21 (3H, s), 2.53 (3H, s), 
2.60 (1H, d, J = 8.5 Hz), 3.59 (1H, m), 3.63 (1H, m), 3.72 (1H, 
dd, J = 3.9 and 10.3 Hz), 3.78 (1H, m), 4.24 (2H, m), 4.46 (1H, 
m), 5.20 (1H, dd, J = 5.6 and 15.4 Hz), 5.48 (1H, d, J = 9.0 Hz), 
5.55 (1H, d, J = 15.1 Hz), 5.60 (1H, dt, J = 6.8 and 15.4 Hz), 5.69 
(1H, d, J = 15.1 Hz), 5.75 (1H, d, J = 9.0 Hz), 5.94 (1H, d, J = 
7.6 Hz), 6.64 (1H, s), 6.66 (1H, s), 7.26-7.44 (10H, m), 7.48-7.65 
(8H, m), 7.77 (2H, d, J = 7.8 Hz), 8.10 (1H, d, J = 7.8 Hz), 8.15 
(1H, d, J = 7.8 Hz); 13C NMR (CDCl3, 75 MHz) δ = 14.1, 18.9, 
20.7, 22.7, 25.8, 26.4, 28.3, 29.1, 29.3, 29.5, 29.6, 29.7, 31.9, 
32.3, 45.5, 47.2, 53.9, 59.4, 63.4, 67.1, 68.9, 73.3, 113.5, 119.9, 
125.2, 127.0, 127.7, 127.8, 128.3, 128.8, 129.4, 129.7, 129.9, 
132.2, 132.4, 133.1, 133.6, 134.6, 135.4, 137.4, 138.7, 141.2, 
143.9, 146.7, 156.2, 158.2, 170.9; HRMS (ESI-TOF) calcd for 








4.2 .3 .  Octadecanoic  ac id  (1R,2E)-1 -{(1S ) -2- ( t er t -
butyld iphenyls i lany loxy)-1-[3-[2 ,4-d imethyl -6 - (2-
n i trobenzyloxy)pheny l] -2-(9H-f luoren-9 -
ylmethoxycarbonylamino)-3-
methylbutyry lamino] ethyl}hexadec-2 -enyl  es ter  (9a,  
b )  
Typical procedure. Triethylamine (56.0 μL, 0.400 mmol), 
EDC·HCl (56.8 mg, 0.300 mmol) and DMAP (0.8 mg, 7 μmol) 
were added to a solution of stearic acid (77.0 mg, 0.270 mmol) in 
CH2Cl2 (0.50 mL) at room temperature. After 30 min of stirring 
at room temperature, alcohol 8a (150 mg, 0.130 mmol) was 
added to the reaction mixture. The resulting solution was stirred 
at the same temperature for 3 h and was quenched by the addition 
of saturated aqueous solution of NaHCO3. The obtained mixture 
was extracted with CH2Cl2, and the organic layer was washed 
with brine, dried over MgSO4, and concentrated in vacuo. The 
obtained residue was purified by column chromatography 
(hexane/AcOEt = 10/1 (v/v)) and 185 mg of ester 9a (99 %) was 
obtained as a colorless amorphousness. 9a: [α]19D +2.22 (c 1.02, 
CHCl3); 1H NMR (CDCl3, 400 MHz) δ = 0.88 (6H, t, J = 6.8 Hz), 
1.01 (9H, s), 1.18-1.31 (52H, m), 1.50 (3H, s), 1.58 (3H, s), 1.88 
(2H, dt, J = 6.6 and 7.1 Hz), 1.99 (3H, s), 2.17 (2H, dt, J = 2.7 
and 7.6 Hz), 2.20 (3H, s), 2.88 (1H, m), 3.25 (1H, m), 4.17 (2H, 
m), 4.24 (1H, m), 4.37 (1H, m), 5.19 (1H, dd, J = 7.1 and 15.4 
Hz), 5.36 (1H, d, J = 8.5 Hz), 5.41 (1H, d, J = 15.4 Hz), 5.34-
5.49 (2H, m), 5.62 (1H, d, J = 15.4 Hz), 5.67 (1H, dt, J = 7.1 and 
15.4 Hz), 5.71 (1H, d, J = 8.5 Hz), 6.23 (1H, s), 6.45 (1H, s), 
7.29 (2H, q, J = 7.8 Hz), 7.35-7.53 (10H, m), 7.55-7.67 (6H, m), 
7.75 (2H, d, J = 7.8 Hz), 8.00 (1H, d, J = 7.8 Hz), 8.16 (1H, d, J 
= 7.8 Hz); 13C NMR (75 MHz, CDCl3) δ = 14.1, 19.1, 20.6, 22.7, 
24.8, 25.5, 26.7, 27.9, 28.9, 29.1, 29.2, 29.3, 29.5, 29.6, 29.7, 
31.9, 32.4, 34.3, 45.2, 47.1, 52.4, 59.3, 61.5, 67.0, 68.8, 73.4, 
113.2, 119.9, 123.5, 125.0, 125.1, 127.0, 127.6, 127.7, 127.8, 
128.3, 128.7, 129.3, 129.4, 129.7, 129.8, 132.7, 133.1, 133.6, 
134.4, 135.5, 135.6, 136.6, 137.0, 138.5, 141.2, 143.9, 146.7, 
156.3, 157.8, 170.3, 172.8; HRMS (ESI-TOF) calcd for 
C87H121N3NaO9Si ([M + Na]+): 1402.8770, found: 1402.8751. 9b: 
[α]19D -6.63 (c 1.43, CHCl3); 1H NMR (CDCl3, 400 MHz) δ = 
0.88 (6H, t, J = 6.6 Hz), 0.97 (9H, s), 1.26 (52H, m), 1.56 (3H, s), 
1.65 (3H, s), 1.90 (2H, dt, J = 6.8 and 7.1 Hz), 2.16 (3H, s), 2.16 
(2H, t, J = 7.3 Hz), 2.53 (3H, s), 3.47 (1H, dd, J = 6.6 and 10.3 
Hz), 3.59 (1H, dd, J = 4.4 and 10.3 Hz), 4.14 (2H, m), 4.26 (1H, 
m), 4.33 (1H, m), 5.10 (2H, m), 5.40 (1H, d, J = 9.0 Hz), 5.45-
5.73 (4H, m), 5.76 (1H, d, J = 9.0 Hz), 6.51 (1H, s), 6.58 (1H, s), 
7.27 (2H, t, J = 7.8 Hz), 7.31-7.43 (9H, m), 7.48-7.63 (7H, m), 
7.74 (2H, d, J = 7.8 Hz), 7.97 (1H, d, J = 7.8 Hz), 8.12 (1H, d, J 
= 7.8 Hz); 13C NMR (CDCl3, 75 MHz) δ = 14.0, 19.1, 20.7, 22.6, 
24.8, 25.8, 26.8, 27.2, 27.9, 29.0, 29.2, 29.3, 29.5, 29.6, 29.7, 
31.9, 32.3, 34.3, 45.1, 47.3, 53.3, 59.9, 62.3, 67.0, 68.9, 74.0, 
113.5, 119.8, 119.9, 124.6, 124.9, 125.1, 125.2, 127.0, 127.6, 
127.7, 128.3, 128.8, 129.6, 129.7, 133.1, 133.8, 134.2, 135.5, 
136.4, 137.0, 138.5, 141.2, 141.3, 144.0, 147.1, 156.1, 158.3, 
170.5, 172.5; HRMS (ESI-TOF) calcd for C87H122N3O9Si ([M + 
H]+): 1380.8950, found: 1380.8928. 
4.2 .4 .  Octadecanoic  ac id  (1R,2E)-1 -[ (1S)-1-{2 -
acetylamino-3 -[2 ,4 -d imethyl-6 - (2-
n i trobenzyloxy)pheny l] -3-methy lbutyrylamino} -2-
( ter t -buty ld iphenyls i lany loxy)ethyl] hexadec-2-eny l  
es ter  (10a,  b )  
Typical procedure. Fmoc derivative 9a (150 mg, 110μmol) 
was treated with 20% (v/v) piperidine/DMF (1.0 mL) at room 
temperature. After 30 min of stirring, the reaction mixture was 
evaporated to remove piperidine and DMF. To the residue 
dissolved in DMF (0.50 mL) was added a preactivated 
acetylation reagent (a 30 min-stirred solution of acetic acid (31.0 
μL, 540 μmol), HOBt·H2O (92.0 mg, 600 μmol), and EDC·HCl 
(100 mg, 540 μmol) in DMF (0.50 mL)). The resulting mixture 
was stirred at room temperature for 3 h and was quenched by the 
addition of saturated aqueous solution of NaHCO3. The mixture 
was extracted with ether, and the organic layer was washed with 
brine, dried over MgSO4, and concentrated in vacuo. The 
obtained residue was purified by column chromatography 
(hexane/AcOEt = 5/1 (v/v)) and 100 mg of compound 10a 
(78 %) was obtained as a colorless oil. 10a: [α]20D +4.33 (c 0.84, 
CHCl3); 1H NMR (CDCl3, 400 MHz) δ = 0.88 (6H, t, J = 6.8 Hz), 
1.01 (9H, s), 1.25 (52H, m), 1.45 (3H, s), 1.47 (3H, s), 1.87 (2H, 
dt, J = 6.3 and 6.8 Hz), 1.98 (3H, s), 1.99 (3H, s), 2.16 (3H, s), 
2.19 (2H, dt, J = 2.7 and 7.6 Hz), 2.79 (1H, dd, J = 9.0 and 10.0 
Hz), 3.18 (1H, dd, J = 4.6 and 10.0 Hz), 4.19 (1H, dddd, J = 3.4, 
4.6, 9.0 and 9.3 Hz), 5.14 (1H, dd, J = 7.3 and 15.4 Hz), 5.31 (1H, 
d, J = 9.3 Hz), 5.37 (1H, d, J = 15.1 Hz), 5.44 (1H, dd, J = 3.4 
and 7.3 Hz), 5.59 (1H, d, J = 9.0 Hz), 5.62 (1H, d, J = 15.1 Hz), 
5.64 (1H, dt, J = 6.8 and 15.4 Hz), 6.19 (1H, s), 6.31 (1H, d, J = 
9.0 Hz), 6.45 (1H, s), 7.36-7.46 (6H, m),7.49 (1H, t, J = 7.8 Hz), 
7.58-7.65 (4H, m), 7.72 (1H, t, J = 7.8 Hz), 8.07 (1H, d, J = 7.8 
Hz), 8.14 (1H, d, J = 7.8 Hz); 13C NMR (CDCl3, 75 MHz) δ = 
14.1, 19.1, 20.6, 22.7, 23.5, 24.8, 25.4, 26.4, 26.7, 28.1, 28.9, 
29.1, 29.3, 29.5, 29.6, 29.7, 31.9, 32.4, 34.3, 45.3, 52.5, 57.2, 
61.4, 68.9, 73.3, 113.2, 123.2, 125.0, 127.7, 127.8, 128.4, 128.7, 
129.5, 129.8, 132.8, 133.5, 134.5, 135.5, 135.6, 136.5, 137.0, 
138.5, 146.7, 157.9, 169.7, 170.5, 172.8; HRMS (ESI-TOF) 
calcd for C74H113N3NaO8Si ([M + Na]+): 1222.8195, found: 
1222.8179. 10b: [α]19D -6.72 (c 0.81, CHCl3); 1H NMR (CDCl3, 
400 MHz) δ = 0.88 (6H, t, J = 6.8 Hz), 0.97 (9H, s), 1.25 (52H, 
m), 1.53 (3H, s), 1.62 (3H, s), 1.89 (2H, dt, J = 6.8 and 7.6 Hz), 
1.92 (3H, s), 2.15 (2H, dt, J = 7.3 and 8.3 Hz), 2.18 (3H, s), 2.51 
(3H, s), 3.44 (1H, dd, J = 6.6 and 10.3 Hz), 3.55 (1H, dd, J = 4.6 
and 10.3 Hz), 4.23 (1H, m), 5.02-5.12 (2H, m), 5.48 (1H, d, J = 
15.4 Hz), 5.57 (1H, dt, J = 6.6 and 13.9 Hz), 5.65 (1H, d, J = 9.3 
Hz), 5.65 (1H, d, J = 9.0 Hz), 5.66 (1H, d, J = 15.4 Hz), 6.36 (1H, 
d, J = 9.0 Hz), 6.53 (1H, s), 6.57 (1H, s), 7.32-7.44 (7H, m), 
7.54-7.60 (4H, m), 7.63 (1H, t, J = 7.8 Hz), 8.05 (1H, d, J = 7.8 
Hz), 8.13 (1H, d, J = 7.8 Hz); 13C NMR (CDCl3, 75 MHz) δ = 
6 
14.1, 19.0, 20.8, 22.7, 23.3, 24.8, 25.8, 26.7, 27.2, 27.9, 29.0, 
29.1, 29.2, 29.3, 29.5, 29.6, 29.7, 31.9, 32.3, 34.3, 45.1, 53.1, 
57.6, 62.2, 69.0, 74.1, 113.4, 124.3, 124.9, 127.7, 128.3, 128.6, 
129.5, 129.6, 129.7, 132.8, 133.9, 134.4, 135.5, 136.6, 137.0, 
138.3, 146.8, 158.3, 169.4, 170.6, 172.6; HRMS (ESI-TOF) 
calcd for C74H113KN3O8Si ([M + K]+): 1238.7934, found: 
1238.7924. 
4.2 .5 .  Octadecanoic  ac id  (1R,2E)-1 -( (1S )-1 -{2 -
acetylamino-3 -[2 ,4 -d imethyl-6 - (2-
n i trobenzyloxy)pheny l] -3-methy lbutyrylamino} -2-
hydroxyethyl )hexadec-2 -enyl  es ter  (11a,  b )  
Typical procedure. To a solution of silylether 10a (80.0 mg, 
66.0 μmol) in THF (0.50 mL) were added TBAF in THF (1 M, 
130 μL, 130 μmol) and AcOH (7.6 μL, 130 μmol) at 0 °C, and 
the mixture was stirred overnight. The reaction was quenched 
with saturated aqueous solution of NaHCO3 and the obtained 
mixture was extracted with CHCl3. The extract was washed with 
brine, dried over MgSO4, and concentrated in vacuo to give a 
crude product, which was purified by column chromatography 
(hexane/AcOEt = 4/1 (v/v)) and 47.0 mg of alcohol 11a (73 %) 
was obtained as a colorless oil. 11a: [α]20D +11.1 (c 1.73, CHCl3); 
1H NMR (CDCl3, 400 MHz) δ = 0.88 (6H, t, J = 6.8 Hz), 1.25 
(52H, m), 1.50 (3H, s), 1.61 (3H, s), 1.84 (1H, m), 1.92 (2H, dt, J 
= 6.8 and 7.1 Hz), 2.00 (3H, s), 2.23 (2H, t, J = 7.6 Hz), 2.24 (3H, 
s), 2.51 (3H, s), 3.02 (1H, m), 3.25 (1H, m), 3.84 (1H, m), 5.07 
(1H, dd, J = 6.1 and 7.6 Hz), 5.24 (1H, dd, J = 7.6 and 15.4 Hz), 
5.47 (1H, d, J = 14.4 Hz), 5.60 (1H, d, J = 9.0 Hz), 5.65 (1H, dt, 
J = 6.8 and 15.4 Hz), 5.74 (1H, d, J = 14.4 Hz), 5.78 (1H, d, J = 
8.5 Hz), 6.25 (1H, d, J = 9.0 Hz), 6.64 (1H, s), 6.69 (1H, s), 7.54 
(1H, t, J = 7.8 Hz), 7.80 (1H, t, J = 7.8 Hz), 8.11 (1H, d, J = 7.8 
Hz), 8.22 (1H, d, J = 7.8 Hz); 13C NMR (CDCl3, 75 MHz) δ = 
14.1, 20.7, 22.7, 23.5, 24.8, 25.7, 26.3, 28.3, 28.8, 29.1, 29.2, 
29.3, 29.4, 29.5, 29.6, 29.7, 31.9, 32.2, 34.3, 45.4, 53.5, 57.2, 
61.3, 68.9, 73.8, 113.2, 124.3, 125.2, 128.6, 128.7, 129.6, 129.9, 
133.2, 134.6, 136.8, 137.5, 138.7, 147.0, 158.2, 169.7, 171.2, 
173.4; HRMS (ESI-TOF) calcd for C58H96N3O8 ([M + H]+): 
962.7197, found: 962.7186. 11b: [α]20D -4.43 (c 1.02, CHCl3); 1H 
NMR (CDCl3, 400 MHz) δ = 0.88 (6H, t, J = 6.8 Hz), 1.25 (52H, 
m), 1.53 (3H, s), 1.58 (3H, s), 1.96 (2H, dt, J = 5.4 and 6.8 Hz), 
1.96 (3H, s), 2.21 (2H, t, J = 7.8 Hz), 2.23 (3H, s), 2.49 (3H, s), 
3.03 (1H, br s), 3.48 (1H, dd, J = 3.9 and 11.7 Hz), 3.59 (1H, m), 
3.80 (1H, m), 4.71 (1H, dd, J = 4.2 and 6.8 Hz), 5.16 (1H, dd, J = 
7.1 and 15.4 Hz), 5.46 (1H, d, J = 14.4 Hz), 5.58 (1H, d, J = 8.8 
Hz), 5.59 (1H, dt, J = 7.1 and 15.4 Hz), 5.74 (1H, d, J = 14.4 Hz), 
6.03 (1H, d, J = 7.1 Hz), 6.30 (1H, d, J = 8.8 Hz), 6.60 (1H, s), 
6.66 (1H, s), 7.54 (1H, t, J = 7.8 Hz), 7.79 (1H, t, J = 7.8 Hz), 
8.06 (1H, d, J = 7.8 Hz), 8.20 (1H, d, J = 7.8 Hz); 13C NMR 
(CDCl3, 75 MHz) δ = 14.1, 20.8, 22.7, 23.4, 24.8, 25.8, 26.8, 
28.2, 28.9, 29.1, 29.2, 29.3, 29.5, 29.6, 29.7, 31.9, 32.2, 34.3, 
45.1, 55.6, 57.6, 61.9, 68.8, 74.5, 113.1, 124.5, 125.2, 128.6, 
128.7, 129.3, 130.0, 133.4, 134.5, 136.4, 137.2, 138.4, 147.2, 
158.1, 169.8, 172.0, 173.4; HRMS (ESI-TOF) calcd for 
C58H96N3O8 ([M + H]+): 962.7197, found: 962.7183. 
4.3. UV-irradiation experiment 
4 .3 .1 .  UV-ir radia t ion  experiment  o f  11a  
To caged ceramide 11a (10.5 mg, 10.9 μmol) was added 
iPrOH (400 μL) containing 0.5% (v/v) Et3N, and the obtained 
mixture was irradiated by UV light (λ > 365 nm) for 1 h. After 
stirring overnight at room temperature, the reaction mixture was 
analyzed by ESI-MS and TLC to confirm the generation of 
ceramide 6. MS (ESI-Ion Trap) calcd for [6 + H]+: 566.6, found 
566.5. TLC (Merck, TLC Silica gel 60 F254) CHCl3/MeOH = 9/1 
(v/v), Rf = 0.4. The Rf value was identical to that of authentic 
sample of ceramide. 
 
4.3 .2 .  UV-ir radia t ion  experiment  o f  10a  
Caged ceramide 10a (30 μg, 0.025 μmol) in iPrOH (120 μL) 
was added to H2O (120 μL) containing 1.0% (v/v) Et3N and the 
obtained mixture was irradiated by UV light (λ > 365 nm) for 3 
min. The resulting mixture was incubated at 37 °C, and reaction 
progress was monitored by HPLC. HPLC conditions: 
hexane/iPrOH = 99/1 (v/v). Retention times, 10a: 17.2 min; 13: 
9.6 min. MS (ESI-Ion Trap) calcd for C52H90NO3Si ([M + H]+), 
804.7, found 804.6. The retention time and MS spectrum were 
identical to that of an authentic sample which was prepared as 
follows. Triethylamine (26 μL, 0.19 mmol), EDC·HCl (21 mg, 
0.11 mmol) and HOBt·H2O (1.8 mg, 0.12 μmol) were added to a 
solution of stearic acid (77 mg, 0.27 mmol) in CH2Cl2 (0.50 mL) 
at room temperature. After 30 min of stirring at room 
temperature, 7 (R = H) (50 mg, 93 μmol) was added to the 
reaction mixture. The resulting solution was stirred at the same 
temperature for 3 h. The reaction mixture was quenched by the 
addition of saturated aqueous solution of NaHCO3. It was 
extracted with CH2Cl2, and the organic layer was washed with 
brine, dried over MgSO4, and concentrated in vacuo. The 
obtained residue was purified by column chromatography 
(hexane/AcOEt = 5/1 (v/v)) and 50 mg of 13 (67 %) was 
obtained as a colorless oil; [α]19D +7.11 (c 1.19, CHCl3); 1H NMR 
(CDCl3, 400 MHz) δ = 0.88 (6H, t, J = 6.8 Hz), 1.07 (9H, s), 1.26 
(52H, m), 2.03 (2H, dt, J = 6.8 and 7.3 Hz), 2.15 (2H, t, J = 7.8 
Hz), 3.56 (1H, d, J = 6.6 Hz), 3.76 (1H, dd, J = 2.4 and 10.0 Hz), 
3.95 (1H, dd, J = 3.2 and 10.0 Hz), 3.98 (1H, m), 4.20 (1H, m), 
5.47 (1H, dd, J = 5.9 and 15.4 Hz), 5.77 (1H, dt, J = 6.8 and 15.4 
Hz), 6.11 (1H, d, J = 7.8 Hz), 7.35-7.48 (6H, m), 7.59-7.65 (4H, 
m); 13C NMR (CDCl3, 75 MHz) δ = 14.1, 19.1, 22.7, 25.8, 26.9, 
29.2, 29.3, 29.4, 29.5, 29.7, 31.9, 32.3, 36.8, 54.0, 64.0, 74.2, 
127.9, 129.0, 130.1, 132.4, 133.4, 135.5, 173.3. HRMS (ESI-
TOF) calcd for C52H89NaNO3Si ([M + Na]+): 826.6509, found: 
826.6484. 
4.4. Introduction of handle on caged ceramide 
4 .4 .1 .  Octadecanoic  ac id  (1R,2E)-1 -( (1S )-1 -{3 -[2 ,4-
d imethyl -6 -(2 -n i trobenzyloxy)pheny l] -3-methyl -2-
pent-4 -ynoylaminobutyrylamino}-2 -
hydroxyethyl )hexadec-2 -enyl  es ter  (14a,  b )  
Typical procedure. Fmoc derivative 9a (100 mg, 72.0 μmol) 
was treated with 20% (v/v) piperidine/DMF (1.0 mL) at room 
temperature. After 30 min of stirring, the reaction mixture was 
evaporated to remove piperidine and DMF. To the residue in 
DMF (0.50 mL) was added preactivated pentynylation reagent (a 
30 min-stirred solution of 3-pentynoic acid (21.0 mg, 210 μmol), 
HOBt·H2O (36.0 mg, 240 μmol), and EDC·HCl (42.0 mg, 220 
μmol) in DMF (0.50 mL)). The resulting mixture was stirred at 
room temperature for 3 h and was quenched by the addition of 
saturated aqueous solution of NaHCO3. The mixture was 
extracted with ether, and the organic layer was washed with brine, 
dried over MgSO4, and concentrated in vacuo. The obtained 
residue was purified by column chromatography (hexane/AcOEt 
= 5/1 (v/v)) and 74.0 mg of the alkyne derivative was obtained as 
a colorless oil. To a solution of the alkyne derivative (74.0 mg, 
60.0 μmol) in THF were added TBAF in THF (1M, 120 μL, 120 
μmol) and AcOH at 0 °C, and the mixture was stirred overnight. 
The reaction was quenched with saturated aqueous solution of 
NaHCO3 and the mixture was extracted with CHCl3. The extract 
was washed with brine, dried over MgSO4, and concentrated in 
vacuo to give a crude product, which was purified by column 
chromatography (hexane/AcOEt = 3/1 (v/v)) and 55.0 mg of 14a 
(76 %) was obtained as a colorless oil. 14a: [α]20D +0.26 (c 0.62, 
CHCl3); 1H NMR (CDCl3, 400 MHz) δ = 0.88 (6H, t, J = 6.8 Hz), 
7 
1.25 (52H, m), 1.53 (3H, s), 1.63 (3H, s), 1.93 (2H, dt, J = 6.8 
and 7.1 Hz), 2.00 (1H, t, J = 2.4 Hz), 2.22 (2H, t, J = 7.6 Hz), 
2.23 (3H, s), 2.41-2.48 (2H, m), 2.48-2.55 (2H, m), 2.52 (3H, s), 
3.06 (1H, br d, J = 11.7 Hz), 3.26 (1H, dd, J = 3.7 and 11.7 Hz), 
3.85 (1H, m), 5.08 (1H, dd, J = 1.0 and 7.3 Hz), 5.24 (1H, dd, J = 
7.3 and 15.4 Hz), 5.52 (1H, d, J = 14.9 Hz), 5.63 (1H, d, J = 8.8 
Hz), 5.65 (1H, dt, J = 6.6 and 15.4 Hz), 5.73 (1H, d, J = 14.9 Hz), 
5.75 (1H, d, J = 7.3 Hz), 6.43 (1H, d, J = 8.8 Hz), 6.75 (1H, s), 
6.78 (1H, s), 7.53 (1H, t, J = 7.8 Hz), 7.78 (1H, t, J = 7.8 Hz), 
8.08 (1H, d, J = 7.8 Hz), 8.21 (1H, d, J = 7.8 Hz); 13C NMR 
(CDCl3, 75 MHz) δ = 14.1, 15.0, 20.7, 22.7, 24.8, 25.7, 26.3, 
28.4, 28.8, 29.1, 29.2, 29.3, 29.4, 29.5, 29.6, 29.7, 31.9, 32.2, 
33.0, 34.3, 35.6, 45.3, 53.6, 57.4, 61.3, 69.0, 69.5, 69.7, 73.8, 
82.9, 113.4, 116.1, 124.3, 125.2, 128.6, 129.6, 129.7, 133.4, 
134.6, 135.0, 136.8, 137.5, 138.7, 146.9, 158.2, 170.6, 171.0, 
173.3; HRMS (ESI-TOF) calcd for C61H98N3O8 ([M + H]+): 
1000.7354, found: 1000.7365. 14b: [α]20D -1.22 (c 0.96, CHCl3); 
1H NMR (CDCl3, 400 MHz) δ = 0.88 (6H, t, J = 6.8 Hz), 1.25 
(52H, m), 1.56 (3H, s), 1.60 (3H, s), 1.97 (2H, dt, J = 6.8 and 7.3 
Hz), 1.99 (1H, t, J = 2.4 Hz), 2.21 (2H, t, J = 7.8 Hz), 2.23 (3H, 
s), 2.37-2.42 (2H, m), 2.44-2.49 (2H, m), 2.50 (3H, s), 3.01 (1H, 
br s), 3.48 (1H, dd, J = 5.9 and 11.7 Hz), 3.58 (1H, br dd, J = 2.4 
and 11.7 Hz), 3.81 (1H, m), 4.71 (1H, dd, J = 4.2 and 6.8 Hz), 
5.16 (1H, dd, J = 7.3 and 15.4 Hz), 5.49 (1H, d, J = 14.6 Hz), 
5.60 (1H, dt, J = 7.1 and 15.4 Hz), 5.62 (1H, d, J = 8.8 Hz), 5.74 
(1H, d, J = 14.6 Hz), 6.04 (1H, d, J = 7.3 Hz), 6.50 (1H, d, J = 
8.8 Hz), 6.60 (1H, s), 6.64 (1H, s), 7.53 (1H, t, J = 7.8 Hz), 7.77 
(1H, t, J = 7.8 Hz), 8.05 (1H, d, J = 7.8 Hz), 8.20 (1H, d, J = 7.8 
Hz); 13C NMR (CDCl3, 75 MHz) δ = 14.1, 14.9, 20.8, 22.6, 24.7, 
25.8, 26.8, 28.2, 28.9, 29.1, 29.2, 29.3, 29.4, 29.6, 29.7, 31.9, 
32.2, 34.2, 35.5, 45.1, 55.5, 57.6, 61.9, 68.8, 69.4, 74.4, 82.9, 
113.2, 124.5, 125.2, 128.6, 129.3, 129.9, 133.5, 134.5, 136.4, 
137.2, 138.4, 147.1, 158.1, 170.7, 171.8, 173.4; HRMS (ESI-
TOF) calcd for C61H98N3O8 ([M + H]+): 1000.7354, found: 
1000.7358. 
4.5. Click chemistry of caged ceramide 
To a solution of alkynyl derivative 14b (8.9 mg, 8.9 μmol) in 
CH2Cl2 (550 μL) were added benzyl azide in CH2Cl2 (0.18 mM, 
150 μL, 27 μmol), CuSO4 in H2O (4.0 μM, 220 μL, 0.89 μmol), 
sodium ascorbate in H2O (5.0 μM, 530 μL, 2.7 μmol) and TBTA 
1616 in CH2Cl2 (19 μM, 47 μL, 0.89 μmol) at room temperature, 
and the mixture was stirred for 3 h. The reaction was quenched 
with saturated aqueous solution of NaHCO3 and the mixture was 
extracted with CHCl3. The extract was washed with brine, dried 
over Na2SO4, and concentrated in vacuo. The obtained crude 
product was purified by column chromatography (hexane/AcOEt 
= 1/1 (v/v)) and 9.0 mg of ligated product 15b (91 %) was 
obtained as a colorless oil; [α]19D +1.05 (c 0.70, CHCl3); 1H NMR 
(400 MHz, CDCl3) δ = 0.88 (6H, t, J = 6.8 Hz), 1.25 (52H, m), 
1.44 (3H, s), 1.67 (3H, s), 1.95 (2H, dt, J = 6.8 and 7.1 Hz), 2.21 
(2H, t, J = 7.6 Hz), 2.22 (3H, s), 2.47 (3H, s), 2.54 (2H, m), 2.95 
(2H, t, J = 7.1Hz), 3.13 (1H, br s), 3.48 (1H, dd, J = 5.4 and 11.0 
Hz), 3.58 (1H, dd, J = 4.9 and 11.0 Hz), 3.85 (1H, m), 4.76 (1H, 
dd, J = 4.4 and 7.1 Hz), 5.14 (1H, dd, J = 7.1 and 15.4 Hz), 5.46 
(1H, d, J = 14.4 Hz), 5.47, (2H, s), 5.52 (1H, d, J = 8.8 Hz), 5.57 
(1H, dt, J = 6.8 and 15.4 Hz), 5.70 (1H, d, J = 14.4 Hz), 6.05 (1H, 
d, J = 7.6 Hz), 6.48 (1H, d, J = 8.8 Hz), 6.59 (1H, s), 6.61 (1H, s), 
7.22 (1H, s), 7.26 (2H, m), 7.35 (3H, m), 7.50 (1H, t, J = 7.6 Hz), 
7.73 (1H, d, J = 7.6 Hz), 7.98 (1H, d, J = 7.6 Hz), 8.16 (1H, d, J 
= 7.6 Hz); 13C NMR (100 MHz, CDCl3) δ = 14.2, 20.9, 21.6, 22.8, 
24.9, 25.9, 26.9, 28.2, 29.0, 29.2, 29.3, 29.4, 29.7, 29.8, 32.0, 
32.3, 34.3, 35.8, 44.8, 54.0, 55.4, 57.9, 61.9, 68.9, 74.4, 113.2, 
121.2, 124.5, 125.2, 128.0, 128.5, 128.6, 128.9, 129.3, 129.8, 
133.5, 134.4, 134.7, 136.3, 137.1, 138.4, 146.8, 147.0, 157.9, 
171.6, 171.7, 173.2; HRMS (ESI-TOF) calcd for C68H104N6NaO8 
([M+Na]+), 1155.7813; found 1155.7806. 
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